Arthritis Advisory Committee: Difference between revisions

← Older edit

Arthritis Advisory Committee (view source)

Revision as of 09:13, 31 March 2025

242 bytes removed , 31 March

no edit summary

CargoAdmin, Bureaucrats, Moderators (CommentStreams), fileuploaders, Interface administrators, newuser, Push subscription managers, Suppressors, Administrators

5,223

edits

@@ Line 1: / Line 1: @@
 {{Organization
 |OrganizationName=Arthritis Advisory Committee
 |OrganizationType=Boards, Commissions, and Committees
-|Mission=The Arthritis Advisory Committee provides expert advice to the FDA on issues related to arthritis, rheumatism, and related diseases. Its mission is to ensure the safety, efficacy, and appropriate use of drug products for these conditions by reviewing scientific data and offering recommendations.
+|Mission=Advise Food and Drug Administration (FDA) on arthritis, rheumatism drugs, ensuring safety, efficacy via data review
+|ParentOrganization=Food and Drug Administration
+|TopOrganization=Department of Health and Human Services
 |OrganizationExecutive=Designated Federal Officer
-|Employees=
-|Budget=
-|Website=https://www.fda.gov/advisory-committees/arthritis-advisory-committee
 |Services=Review of drug applications; safety and efficacy assessments; policy consultation
-|ParentOrganization=Food and Drug Administration
+|HeadquartersLocation=38.99583, -77.02639
-|TopOrganization=Department of Health and Human Services
-|CreationLegislation=
-|Regulations=
-|HeadquartersLocation=38.995833, -77.026389
 |HeadquartersAddress=10903 New Hampshire Ave, Silver Spring, MD 20993
+|Website=https://www.fda.gov/advisory-committees/arthritis-advisory-committee
 }}
 '''Arthritis Advisory Committee (AAC)''' is part of the U.S. Food and Drug Administration (FDA) and advises on matters concerning the treatment of arthritis, rheumatism, and related conditions. Located in Silver Spring, Maryland, the committee evaluates data on drug safety, effectiveness, and labeling related to these diseases.